These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 24698233)

  • 1. Female gender and contrast-induced nephropathy in primary percutaneous intervention for ST-segment elevation myocardial infarction.
    Lucreziotti S; Centola M; Salerno-Uriarte D; Ponticelli G; Battezzati PM; Castini D; Sponzilli C; Lombardi F
    Int J Cardiol; 2014 Jun; 174(1):37-42. PubMed ID: 24698233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age, glomerular filtration rate, ejection fraction, and the AGEF score predict contrast-induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
    Andò G; Morabito G; de Gregorio C; Trio O; Saporito F; Oreto G
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):878-85. PubMed ID: 23703775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ratio of contrast volume to glomerular filtration rate predicts outcomes after percutaneous coronary intervention for ST-segment elevation acute myocardial infarction.
    Mager A; Vaknin Assa H; Lev EI; Bental T; Assali A; Kornowski R
    Catheter Cardiovasc Interv; 2011 Aug; 78(2):198-201. PubMed ID: 20949583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction.
    Marenzi G; Lauri G; Assanelli E; Campodonico J; De Metrio M; Marana I; Grazi M; Veglia F; Bartorelli AL
    J Am Coll Cardiol; 2004 Nov; 44(9):1780-5. PubMed ID: 15519007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Terminal Fragment of Pro B-type Natriuretic Peptide as a Marker of Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction.
    Goussot S; Mousson C; Guenancia C; Stamboul K; Brunel P; Brunet D; Touzery C; Cottin Y; Zeller M
    Am J Cardiol; 2015 Sep; 116(6):865-71. PubMed ID: 26183794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of the severity of contrast induced nephropathy to SYNTAX score and long term prognosis in patients treated with primary percutaneous coronary intervention.
    Oduncu V; Erkol A; Karabay CY; Şengül C; Tanalp AC; Fotbolcu H; Özveren O; Bitigen A; Pala S; Kırma C
    Int J Cardiol; 2013 Oct; 168(4):3480-5. PubMed ID: 23688433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention without acute left ventricular ejection fraction impairment.
    Pyxaras SA; Sinagra G; Mangiacapra F; Perkan A; Di Serafino L; Vitrella G; Rakar S; De Vroey F; Santangelo S; Salvi A; Toth G; Bartunek J; De Bruyne B; Wijns W; Barbato E
    Am J Cardiol; 2013 Mar; 111(5):684-8. PubMed ID: 23261003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive Value of Gamma-Glutamyl Transferase Levels for Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention.
    Oksuz F; Yarlioglues M; Cay S; Celik IE; Mendi MA; Kurtul A; Cankurt T; Kuyumcu S; Canpolat U; Turak O
    Am J Cardiol; 2015 Sep; 116(5):711-6. PubMed ID: 26116992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-Induced Nephropathy and Long-Term Mortality After Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction.
    Sun G; Chen P; Wang K; Li H; Chen S; Liu J; He Y; Song F; Liu Y; Chen JY
    Angiology; 2019 Aug; 70(7):621-626. PubMed ID: 30317864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of iso-osmolar contrast use in emergent percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Kanei Y; Ayabe K; Ratcliffe J; Vales L; Nakra N; Friedman P; Fox J
    J Invasive Cardiol; 2011 Nov; 23(11):448-50. PubMed ID: 22045075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Association between high-sensitivity C-reactive protein and contrast-induced nephropathy after primary percutaneous coronary intervention].
    He YT; Tan N; Liu YH; Chen SQ; Liu Y; Huang SJ; Yang DH; Ye P; Ran P
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 May; 41(5):394-8. PubMed ID: 24021122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ratio of contrast volume to glomerular filtration rate predicts in-hospital and six-month mortality in patients undergoing primary angioplasty for ST-elevation myocardial infarction.
    Çiçek G; Bozbay M; Açıkgöz SK; Altay S; Uğur M; Köroğlu B; Uyarel H
    Cardiol J; 2015; 22(1):101-7. PubMed ID: 24671903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Chronic Statin Therapy on Postprocedural Contrast-Induced Nephropathy in Patients Undergoing Non-Emergent Percutaneous Coronary Intervention.
    Chanin JM; Yang DC; Haider MA; Swaminathan RV; Kim LK; Charitakis K; Tanoue M; Minutello RM; Gade CL; Singh HS; Bergman G; Wong SC; Feldman DN
    J Invasive Cardiol; 2015 Nov; 27(11):490-6. PubMed ID: 25999136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of contrast-induced nephropathy with N-acetylcysteine or sodium bicarbonate in patients with ST-segment-myocardial infarction: a prospective, randomized, open-labeled trial.
    Thayssen P; Lassen JF; Jensen SE; Hansen KN; Hansen HS; Christiansen EH; Junker A; Ravkilde J; Thuesen L; Veien KT; Jensen LO
    Circ Cardiovasc Interv; 2014 Apr; 7(2):216-24. PubMed ID: 24714489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention.
    Iakovou I; Dangas G; Mehran R; Lansky AJ; Ashby DT; Fahy M; Mintz GS; Kent KM; Pichard AD; Satler LF; Stone GW; Leon MB
    J Invasive Cardiol; 2003 Jan; 15(1):18-22. PubMed ID: 12499523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does N-terminal pro-brain natriuretic peptide add prognostic value to the Mehran risk score for contrast-induced nephropathy and long-term outcomes after primary percutaneous coronary intervention?
    Liu YH; Jiang L; Chen JY; Tan N; Liu Y; He PC
    Int Urol Nephrol; 2016 Oct; 48(10):1675-82. PubMed ID: 27473154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium bicarbonate plus N-acetylcysteine to prevent contrast-induced nephropathy in primary and rescue percutaneous coronary interventions: the BINARIO (BIcarbonato e N-Acetil-cisteina nell'infaRto mIocardico acutO) study.
    Leone AM; De Caterina AR; Sciahbasi A; Aurelio A; Basile E; Porto I; Trani C; Burzotta F; Niccoli G; Mongiardo R; Mazzari MA; Buffon A; Panocchia N; Romagnoli E; Lioy E; Rebuzzi AG; Crea F
    EuroIntervention; 2012 Nov; 8(7):839-47. PubMed ID: 23171803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is atrial fibrillation a risk factor for contrast-induced nephropathy in patients with ST-elevation myocardial infarction?
    Ballı M; Taşolar H; Çetin M; Hatem E; Çağlıyan ÇE; Şeker T; Çaylı M
    J Cardiol; 2016 Apr; 67(4):327-30. PubMed ID: 26589269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Acidosis Soon After Reperfusion and Contrast-Induced Nephropathy in Patients With a First-Time ST-Segment Elevation Myocardial Infarction.
    Gohbara M; Hayakawa A; Akazawa Y; Furihata S; Kondo A; Fukushima Y; Tomari S; Endo T; Kimura K; Tamura K
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28835362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-sensitivity C-reactive protein predicts contrast-induced nephropathy after primary percutaneous coronary intervention.
    Liu Y; Tan N; Zhou YL; Chen YY; Chen JY; Chen J; Luo JF
    J Nephrol; 2012; 25(3):332-40. PubMed ID: 21928234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.